Groupe la Francaise Has $6.45 Million Stock Holdings in Danaher Corporation $DHR

Groupe la Francaise trimmed its position in Danaher Corporation (NYSE:DHR) by 67.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,035 shares of the conglomerate’s stock after selling 70,058 shares during the quarter. Groupe la Francaise’s holdings in Danaher were worth $6,453,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kennebec Savings Bank raised its stake in Danaher by 1.4% during the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after acquiring an additional 46 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in shares of Danaher by 2.6% in the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after purchasing an additional 47 shares in the last quarter. High Note Wealth LLC grew its stake in shares of Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. increased its holdings in shares of Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after purchasing an additional 47 shares during the period. Finally, GW&K Investment Management LLC raised its stake in shares of Danaher by 8.4% during the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

NYSE:DHR opened at $195.25 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average price is $188.36 and its 200 day moving average price is $195.66. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market cap of $137.26 billion, a P/E ratio of 34.68, a PEG ratio of 2.44 and a beta of 0.79.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the company earned $0.77 EPS. Danaher’s revenue was up 5.5% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Friday, June 26th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s dividend payout ratio is currently 28.42%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on DHR shares. TD Cowen reduced their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Argus reduced their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Piper Sandler initiated coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. Finally, Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.